Trial Profile
A randomized, open-label, pilot study of a Fuzeon-containing [enfuvirtide] combination therapy compared with standard combination antiretroviral therapy on viral load in treatment-naive patients with HIV infection
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Jun 2011
Price :
$35
*
At a glance
- Drugs Enfuvirtide (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Therapeutic Use
- Sponsors Roche
- 23 Feb 2010 Planned number of patients changed from 30 to 31 as reported by Roche record.
- 19 Sep 2008 Status changed from active, no longer recruiting to completed, as reported by Roche.
- 02 Jun 2006 New trial record.